87
Participants
Start Date
December 15, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
CHS-114
CHS-114
toripalimab
toripalimab-tpzi
RECRUITING
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
RECRUITING
Emory Winship Cancer Institute, Atlanta
RECRUITING
SCRI Lake Nona DDU (FL Cancer Specialists), Orlando
RECRUITING
Vanderbilt-Ingram Cancer Center, Nashville
RECRUITING
University of Louisville, Louisville
RECRUITING
University of Cincinnati, Cincinnati
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center, Detroit
RECRUITING
Hope & Healing Cancer Services, Hinsdale
RECRUITING
Washington University, St Louis
RECRUITING
START- San Antonio, San Antonio
RECRUITING
START Mountain, West Valley City
RECRUITING
Hoag Memorial Hospital, Newport Beach
RECRUITING
FOMAT Medical Research, Oxnard
RECRUITING
Stanford Cancer Center, Palo Alto
RECRUITING
University of Washington/Fred Hutchinson Cancer Center, Seattle
Lead Sponsor
Coherus Oncology, Inc.
INDUSTRY